tirzepatide head to head semaglutide SURPASS-2 (NEJM 2021) was the definitive head-to-head: vs 1.0 mg (the maximum approved T2DM dose) in 1,879 patients with type 2 diabetes. All three tirzepatide doses produced superior HbA1c reductions Switching from semaglutide to tirzepatide

Then divide your target dose by the concentration to get the volume you need to inject

If you are experiencing injection site reactions at a given dose, extending that period to 6 or 8 weeks before escalating gives your body additional time to develop tolerance

We routinely incorporate these medications into pre-surgical weight loss plans, helping patients achieve a safe weight to receive the bariatric procedure of their choice

doi:10.1038/nrendo.2015.3 13

The most commonly reported side effects of semaglutide include gastrointestinal issues, such as nausea, vomiting, diarrhea and constipation

Co-first authors Dylan Rausch, Mette Ludwig and Marie Aare Bentsen from Novo Nordisk A/S are all CBMR alumni